Menu
होम >> Schemes >> तपेदिक और कालाजार स्‍कीम

तपेदिक और कालाजार स्‍कीम

तपेदिक और कालाजार स्‍कीम

Department of Pharmaceuticals is running following two interdepartmental collaborative projects with NIPER, Mohali for development of new drugs for Tuberculosis and Kala Azar.

  1. Target specific New Drug Discovery for Anti Tubercular Agents

    Project on Target specific New Drug Discovery for Anti Tubercular Agents aims at discovering high affinity ligands that can be developed into efficacious and less toxic drugs against TB. Among other things, this proposal use technique of post genomic era in identifying the role of specific gene in causing and counteracting diseases. Phase I of the project has duration of 3 years and Phase II of 2 years. The total cost of the project is Rs. 4,88,00,000/-.The fund is to be released in four equal instalments of Rs.1.22 crore for the project.
  2. Target specific New Drug Discovery against Kala Azar

    The Kala Azar Project aims at discovering new drugs to fight against Kala Azar. The focus of the Project is to putting together a concerted effort to discover high affinity ligands that can be developed into efficacious and less toxic drugs against Kala Azar. It also consists of two phases. Phase I of the project has duration of 3 years and phase II of 2 years. The cost of project is Rs. 4,88,00,000/-. The fund is to be released in four equal instalments of Rs.1.22 cr for the project.